Philipp Kanis

Philipp Kanis

Auto-generated profile, based on publicly available information

Philipp Kanis

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRStephan Riesenberg
Stephan Riesenberg
NHNelly Helmbrecht
Nelly Helmbrecht
PKPhilipp Kanis
Philipp Kanis
TMTomislav Maricic
Tomislav Maricic
SPSvante Pääbo
Svante Pääbo
The first step in CRISPR-Cas9-mediated genome editing is the cleavage of target DNA sequences that are complementary to so-called spacer sequences in CRISPR guide RNAs (gRNAs). However, some DNA sequences are refractory to CRISPR-Cas9 cleavage, which is at least in part due to gRNA misfolding. To overcome this problem, we have engineered gRNAs with highly stable hairpins in their constant parts and further enhanced their stability by chemical modifications. The ‘Genome-editing Optimized Locked Design’ (GOLD)-gRNA increases genome editing efficiency up to around 1000-fold (from 0.08 to 80.5%) with a mean increase across different other targets of 7.4-fold. We anticipate that this improved gRNA will allow efficient editing regardless of spacer sequence composition and will be especially useful if a desired genomic site is difficult to edit.

20 July 2023 in Nature Methods
Verified
Journal Article
Open access
PDF file
SRStephan Riesenberg
Stephan Riesenberg
PKPhilipp Kanis
Philipp Kanis
DMDominik Macak
Dominik Macak
DWDamian Wollny
Damian Wollny
DDDorothee Düsterhöft
Dorothee Düsterhöft
SPSvante Pääbo
Svante Pääbo
Homology-directed repair (HDR), a method for repair of DNA double-stranded breaks can be leveraged for the precise introduction of mutations supplied by synthetic DNA donors, but remains limited by low efficiency and off-target effects. In this study, we report HDRobust, a high-precision method that, via the combined transient inhibition of nonhomologous end joining and microhomology-mediated end joining, resulted in the induction of point mutations by HDR in up to 93% (median 60%, s.e.m. 3) of chromosomes in populations of cells. We found that, using this method, insertions, deletions and rearrangements at the target site, as well as unintended changes at other genomic sites, were largely abolished. We validated this approach for 58 different target sites and showed that it allows efficient correction of pathogenic mutations in cells derived from patients suffering from anemia, sickle cell disease and thrombophilia.

29 July 2022 in Science Advances
Verified
Journal Article
Open access
FMFelipe Mora-Bermúdez
Felipe Mora-Bermúdez
PKPhilipp Kanis
Philipp Kanis
DMDominik Macak
Dominik Macak
JPJula Peters
Jula Peters
RNRonald Naumann
Ronald Naumann
SPSvante Pääbo
Svante Pääbo
Since the ancestors of modern humans separated from those of Neanderthals, around 100 amino acid substitutions spread to essentially all modern humans. The biological significance of these changes is largely unknown. Here, we examine all six such amino acid substitutions in three proteins known to have key roles in kinetochore function and chromosome segregation and to be highly expressed in the stem cells of the developing neocortex. When we introduce these modern human-specific substitutions in mice, three substitutions in two of these proteins, KIF18a and KNL1, cause metaphase prolongation and fewer chromosome segregation errors in apical progenitors of the developing neocortex. Conversely, the ancestral substitutions cause shorter metaphase length and more chromosome segregation errors in human brain organoids, similar to what we find in chimpanzee organoids. These results imply that the fidelity of chromosome segregation during neocortex development improved in modern humans after their divergence from Neanderthals.

15 October 2021 in Science
Verified
Journal Article
Closed access
TMTomislav Maricic
Tomislav Maricic
NHNelly Helmbrecht
Nelly Helmbrecht
SRStephan Riesenberg
Stephan Riesenberg
DMDominik Macak
Dominik Macak
PKPhilipp Kanis
Philipp Kanis
SPSvante Pääbo
Svante Pääbo
Trujillo et al . (Research Articles, 12 February 2021, eaax2537) conclude that the reintroduction of an ancestral amino acid substitution in the protein NOVA1 drastically alters the development of brain organoids. We show that cell lines used by the authors carry heterozygous deletions of the target DNA sequence, providing another plausible explanation for the effects observed.

10 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDominik Macak
Dominik Macak
PKPhilipp Kanis
Philipp Kanis
SRStephan Riesenberg
Stephan Riesenberg
We evaluate the effect of most FDA-approved drugs (>7,000 conditions) on double-strand DNA break repair pathways by analyzing mutational outcomes in human induced pluripotent stem cells. We identify drugs that can be repurposed as inhibitors and enhancers of repair outcomes attributed to non-homologous and microhomology-mediated end joining (NHEJ, MMEJ), and homology-directed repair (HDR). We also identify functions of the proteins estrogen receptor 2 (ESR2) and aldehyde oxidase 1 (AOX1), affecting several key DNA repair proteins, such as ATM and 53BP1. Silencing of ESR2 can have a synergistic effect on increasing HDR when combined with NHEJ inhibition (mean 4.6-fold increase). We further identify drugs that induce synthetic lethality when NHEJ or HDR is blocked and may therefore be candidates for precision medicine. We anticipate that the ability to modulate the DNA repair outcomes with clinically safe drugs will help disease modeling, gene therapy, chimeric antigen receptor immunotherapy, and cancer treatment.

21 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRStephan Riesenberg
Stephan Riesenberg
PKPhilipp Kanis
Philipp Kanis
RKRosa Karlić
Rosa Karlić
TMTomislav Maricic
Tomislav Maricic
The ability to robustly predict guide RNA (gRNA) activity is a long-standing goal for CRISPR applications, as it would reduce the need to pre-screen gRNAs. Quantification of formation of short insertions and deletions (indels) after DNA cleavage by transcribed gRNAs has been typically used to measure and predict gRNA activity. We evaluate the effect of chemically synthesized Cas9 gRNAs on different cellular DNA cleavage outcomes and find that the activity of different gRNAs is largely similar and often underestimated when only indels are scored. We provide a simple linear model that reliably predicts synthetic gRNA activity across cell lines, robustly identifies inefficient gRNAs across different published datasets, and is easily accessible via online genome browser tracks. In addition, we develop a homology-directed repair efficiency prediction tool and show that unintended large-scale repair events are common for Cas9 but not for Cas12a, which may be relevant for safety in gene therapy applications.